Federal award
TECHWERKS LLC
HT942525F0032
Contract
Obligated and Ceiling
- Obligated (net)
- $2,781,027.62
- Ceiling (potential value, not spending)
- $16,789,685.35
- Current value
- $3,434,994.78
- Gross positive obligations
- $2,819,827.35
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- TECHWERKS LLC · EZ5GN68ZNDN9
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- TECHWERKS LLC · EZ5GN68ZNDN9
- Awarding agency
- Department of War · sub-agency 97DH · office HT9426
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- AN41 · HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- HT942525F0032
- Parent vehicle (IDV PIID)
- HT001122D0047
- Award type code
- C
- Actions
- 9 · Nov 19, 2024 to Jun 15, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 15, 2026 | FY2026 | P00008 | B | $566,406.02 | — |
| Dec 23, 2025 | FY2026 | P00007 | C | $150,000.00 | — |
| Oct 24, 2025 | FY2026 | P00006 | G | $250,000.00 | — |
| Sep 19, 2025 | FY2025 | P00005 | C | $22,740.00 | — |
| Jul 29, 2025 | FY2025 | P00004 | C | $56,009.31 | — |
| Jun 12, 2025 | FY2025 | P00003 | C | −$38,799.73 | — |
| Apr 4, 2025 | FY2025 | P00002 | M | $0.00 | — |
| Mar 14, 2025 | FY2025 | P00001 | C | $796,531.22 | — |
| Nov 19, 2024 | FY2025 | 0 | — | $978,140.80 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.